GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SkinBioTherapeutics PLC (LSE:SBTX) » Definitions » NonCurrent Deferred Liabilities

SkinBioTherapeutics (LSE:SBTX) NonCurrent Deferred Liabilities : £0.00 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is SkinBioTherapeutics NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

SkinBioTherapeutics's non-current deferred liabilities for the quarter that ended in Dec. 2023 was £0.00 Mil.

SkinBioTherapeutics NonCurrent Deferred Liabilities Historical Data

The historical data trend for SkinBioTherapeutics's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SkinBioTherapeutics NonCurrent Deferred Liabilities Chart

SkinBioTherapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial - - - - -

SkinBioTherapeutics Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

SkinBioTherapeutics NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of SkinBioTherapeutics's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


SkinBioTherapeutics (LSE:SBTX) Business Description

Traded in Other Exchanges
N/A
Address
Bath Lane, The Core, Newcastle Helix, Newcastle upon Tyne, GBR, NE4 5TF
SkinBioTherapeutics PLC is a life science company focused on skin health. It is focused on the development of technology to protect, manage, and restore skin utilizing proteins found in the human microbiota. It is targeting three specific skin healthcare sectors; cosmetics, infection control, and eczema.

SkinBioTherapeutics (LSE:SBTX) Headlines

From GuruFocus